Global Point-of-Care (POC) Diagnostics Market Size, Share, Growth, and Forecast 2026-2035 | Decentralized and Home Testing Drive 8.5% CAGR Toward USD 36.92 Billion
Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "Point-of-Care (POC) Diagnostic Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)" has been added to ResearchAndMarkets.com's offering.
The global point-of-care (POC) diagnostic market was valued at USD 16.33 Billion in 2025 and is projected to grow at a CAGR of 8.50% from 2026 to 2035, reaching USD 36.92 Billion by 2035. Market expansion is supported by increasing demand for rapid testing, decentralised healthcare services, chronic disease management, home-based diagnostics, and immediate clinical decision-making.
Point-of-Care (POC) Diagnostic Market Growth Drivers
Healthcare providers are increasingly adopting point-of-care diagnostic solutions to reduce turnaround times and support timely treatment decisions. Demand is particularly strong in emergency care, critical care, infectious disease management, diabetes monitoring, and cardiovascular care. Technological advances in molecular diagnostics, immunoassays, microfluidics, and connected testing platforms are also improving analytical performance and expanding the range of tests available outside centralised laboratories.
Strategic acquisitions are strengthening the capabilities of leading point-of-care diagnostic companies. In January 2025, bioMerieux acquired SpinChip Diagnostics ASA, a Norwegian developer of immunoassay platforms for near-patient testing. SpinChip's benchtop analyser can process whole blood samples and provide results within 10 minutes while maintaining laboratory-level sensitivity. The acquisition is expected to enhance bioMerieux's decentralised testing portfolio and support broader access to rapid diagnostics.
In July 2024, Roche completed its acquisition of LumiraDx's point-of-care technology. The acquired multi-assay platform supports immunoassay and clinical chemistry testing and offers potential expansion into molecular diagnostics. The transaction strengthens Roche's position in decentralised testing and broadens its ability to deliver timely, actionable results across clinical and community healthcare settings.
Key Point-of-Care Diagnostic Market Trends
Point-of-Care (POC) Diagnostic Market Segmentation
The market is analysed by product, platform, mode of purchase, end user, and region.
Point-of-Care Diagnostic Market Share
Glucose monitoring kits are expected to account for a leading share of the market, supported by the increasing global prevalence of diabetes and growing demand for continuous disease management. Portable monitors, smartphone connectivity, wearable integration, and real-time data tracking are improving usability and supporting adoption in clinical and home-based environments. The global glucose monitoring devices market is projected to expand at a CAGR of 11.3% from 2025 to 2034.
Infectious diseases testing kits are also anticipated to record substantial demand. Their ability to support rapid pathogen identification is essential during outbreaks and in resource-limited settings. Advances in molecular diagnostics and multiplex testing are improving testing efficiency, while government initiatives and public health programmes continue to strengthen infectious disease surveillance.
Hospitals/Critical Care Centres are expected to remain a significant end-user segment because of their high testing volumes and requirement for immediate results. Integration of point-of-care devices into emergency, inpatient, and intensive care workflows can improve operational efficiency and accelerate clinical interventions.
Regional Market Outlook
North America is expected to hold the largest share of the global point-of-care diagnostic market. Growth is supported by advanced healthcare infrastructure, substantial research and development investment, strong adoption of medical technology, and a high prevalence of diabetes and cardiovascular disease. Supportive regulatory and reimbursement frameworks also improve access to diagnostic products.
Europe represents another major market, driven by decentralised healthcare initiatives, home-based testing, infectious disease programmes, preventive healthcare policies, and an ageing population. The increasing use of artificial intelligence and connected diagnostic systems is expected to create additional opportunities across the region. Asia Pacific, Latin America, and the Middle East and Africa also offer growth potential as healthcare access expands and demand for affordable rapid testing increases.
Leading Point-of-Care Diagnostic Companies
Prominent companies operating in the market include Abbott Point of Care Inc., F. Hoffmann-La Roche Ltd, Chembio Diagnostics, Inc., Johnson & Johnson Services, Inc., Siemens AG, Danaher Corp, and Becton, Dickinson and Company.
Abbott Point of Care Inc. offers the i-STAT platform for portable testing of blood gases, electrolytes, cardiac markers, and other critical care parameters. F. Hoffmann-La Roche Ltd provides point-of-care solutions through platforms including cobas and Accu-Chek, with applications across diabetes, infectious diseases, and oncology. Chembio Diagnostics, Inc. focuses on rapid infectious disease tests using technologies such as its Dual Path Platform. Other leading participants continue to invest in product development, partnerships, acquisitions, and connected diagnostic technologies to strengthen their global market positions.
The point-of-care (POC) diagnostic market outlook for 2026-2035 remains positive as healthcare systems prioritise faster results, decentralised testing, personalised care, and improved access. Continued innovation in portable analysers, wearable biosensors, molecular testing, and multi-assay platforms is expected to support sustained market growth through 2035.
Key Topics Covered
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Point-of-Care (POC) Diagnostic Market Overview
3.1 Global Point-of-Care (POC) Diagnostic Market Historical Value (2019-2025)
3.2 Global Point-of-Care (POC) Diagnostic Market Forecast Value (2026-2035)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Point-of-Care (POC) Diagnostic Market Landscape*
5.1 Global Point-of-Care (POC) Diagnostic Market: Developers Landscape
5.1.1 Analysis By Year Of Establishment
5.1.2 Analysis By Company Size
5.1.3 Analysis By Region
5.2 Global Point-of-Care (POC) Diagnostic Market: Product Landscape
5.2.1 Analysis by Product
5.2.2 Analysis by Application
6 Global Point-of-Care (POC) Diagnostic Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter's Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Point-of-Care (POC) Diagnostic Market Segmentation (2019-2035)
7.1 Global Point-of-Care (POC) Diagnostic Market by Product
7.1.1 Market Overview
7.1.2 Glucose Monitoring Kits
7.1.3 Infectious Diseases Testing Kits
7.1.4 Pregnancy and Fertility Testing Kits
7.1.5 Haematology Testing Kits
7.1.6 Cardiometabolic Monitoring Kits
7.1.7 Urinalysis Testing Devices
7.1.8 Coagulation Monitoring Kits
7.1.9 Tumour or Cancer Markers Testing Devices
7.1.10 Cholesterol Testing Strips
7.1.11 Drugs of Abuse Testing Kits
7.1.12 Faecal Occult Testing Kits
7.1.13 Others
7.2 Global Point-of-Care (POC) Diagnostic Market by Platform
7.2.1 Market Overview
7.2.2 Lateral Flow Assays
7.2.3 Dipsticks
7.2.4 Microfluidics
7.2.5 Molecular Diagnostics
7.2.6 Immunoassays
7.2.7 Others
7.3 Global Point-of-Care (POC) Diagnostic Market by Mode of Purchase
7.3.1 Market Overview
7.3.2 Prescription-Based Products
7.3.3 OTC Products
7.4 Global Point-of-Care (POC) Diagnostic Market by End User
7.4.1 Market Overview
7.4.2 Diagnostic Centers
7.4.3 Hospitals/Critical Care Centers
7.4.4 Assisted Living Healthcare Facilities
7.4.5 Research Laboratories
7.5 Global Point-of-Care (POC) Diagnostic Market by Region
7.5.1 Market Overview
7.5.2 North America
7.5.3 Europe
7.5.4 Asia Pacific
7.5.5 Latin America
7.5.6 Middle East and Africa
8 North America Point-of-Care (POC) Diagnostic Market Segmentation (2019-2035)
8.1 Market by Product
8.2 Market by Platform
8.3 Market by Mode of Purchase
8.4 Market by End User
8.5 Market by Country
8.5.1 United States of America
8.5.1.1 Market by Product
8.5.2 Canada
8.5.2.1 Market by Product
9 Europe Point-of-Care (POC) Diagnostic Market Segmentation (2019-2035)
9.1 Market by Product
9.2 Market by Platform
9.3 Market by Mode of Purchase
9.4 Market by End User
9.5 Market by Country
9.5.1 United Kingdom
9.5.1.1 Market by Product
9.5.2 Germany
9.5.2.1 Market by Product
9.5.3 France
9.5.3.1 Market by Product
9.5.4 Italy
9.5.4.1 Market by Product
9.5.5 Others
10 Asia Pacific Point-of-Care (POC) Diagnostic Market Segmentation (2019-2035)
10.1 Market by Product
10.2 Market by Platform
10.3 Market by Mode of Purchase
10.4 Market by End User
10.5 Market by Country
10.5.1 China
10.5.1.1 Market by Product
10.5.2 Japan
10.5.2.1 Market by Product
10.5.3 India
10.5.3.1 Market by Product
10.5.4 ASEAN
10.5.4.1 Market by Product
10.5.5 Australia
10.5.5.1 Market by Product
10.5.6 Others
11 Latin America Point-of-Care (POC) Diagnostic Market Segmentation (2019-2035)
11.1 Market by Product
11.2 Market by Platform
11.3 Market by Mode of Purchase
11.4 Market by End User
11.5 Market by Country
11.5.1 Brazil
11.5.1.1 Market by Product
11.5.2 Argentina
11.5.2.1 Market by Product
11.5.3 Mexico
11.5.3.1 Market by Product
11.5.4 Others
12 Middle East and Africa Point-of-Care (POC) Diagnostic Market Segmentation (2019-2035)
12.1 Market by Product
12.2 Market by Platform
12.3 Market by Mode of Purchase
12.4 Market by End User
12.5 Market by Country
12.5.1 Saudi Arabia
12.5.1.1 Market by Product
12.5.2 United Arab Emirates
12.5.2.1 Market by Product
12.5.3 Nigeria
12.5.3.1 Market by Product
12.5.4 South Africa
12.5.4.1 Market by Product
12.5.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Strategic Initiatives
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Initiatives
15.3 Analysis by Joint Ventures
15.4 Analysis by Leading Players
15.5 Analysis by Geography
16 Supplier Landscape
16.1 Market Share Analysis, By Region (Top 5 Companies)
16.2 Abbott Point of Care Inc.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Company News and Developments
16.2.5 Certifications
16.3 F. Hoffmann-La Roche Ltd
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Company News and Developments
16.3.5 Certifications
16.4 Chembio Diagnostics, Inc.
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Company News and Developments
16.4.5 Certifications
16.5 Johnson & Johnson Services, Inc.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Company News and Developments
16.5.5 Certifications
16.6 Siemens AG
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Company News and Developments
16.6.5 Certifications
16.7 Becton, Dickinson and Company
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Company News and Developments
16.7.5 Certifications
16.8 Danaher Corp
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Company News and Developments
16.8.5 Certifications
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
For more information about this report visit https://www.researchandmarkets.com/r/t8xbkp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.